| Financial Year |
March 31 2023 |
| Monetary Funds |
1,610,333,565.12 |
| Held-for-trading Financial Assets |
1,558,332,368.14 |
| Notes Receivable |
694,400.00 |
| Accounts Receivable |
975,768,235.92 |
| Advances to Suppliers |
10,929,899.65 |
| Other Receivables |
48,886,192.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
604,555,878.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,863,088.25 |
| Total Current Assets |
4,878,704,657.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,314,551,007.42 |
| Investment Properties |
138,755,703.38 |
| Fixed Assetes |
1,582,828,934.75 |
| Under-construction Projects |
152,639,364.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
395,603,795.01 |
| R&D expenses |
-- |
| Goodwill |
678,448,513.59 |
| Long-Term Deferred and Prepaid Expenses |
6,651,534.13 |
| Deferred Income Tax Assets |
223,302,890.11 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
7,404,603,948.63 |
| Total Assets |
12,283,308,606.50 |
| Short-Term Loans |
55,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
515,011,130.60 |
| Accounts Received In Advance |
3,265,467.98 |
| Employee Compensation Payable |
262,645,877.13 |
| Taxes Payable |
139,319,927.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
157,690,221.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,415,883.36 |
| Other Current Liabilities |
305,258,151.46 |
| Sub-Total of Current Liabilities |
4,218,147,303.31 |
| Long-term Loans |
137,793,575.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
38,245,399.85 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,612,432.96 |
| Deferred Income Tax Liabilities |
77,072,943.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
334,891,368.68 |
| Total Liabilities |
4,553,038,671.99 |
| Paid-In Capital(Or Share Stock) |
1,900,006,442.00 |
| Capital Surplus |
479,904,689.09 |
| Surplus Reserve |
425,444,965.19 |
| LESS:Treasury Stock |
82,071,296.27 |
| Undistributed Profits |
4,321,710,247.08 |
| Minority Stockholder's Interest |
677,223,408.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,053,046,526.25 |
| Owner's Equity（Stockholder's Equity） |
7,730,269,934.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,283,308,606.50 |
